BR0211619A - Uso de pentraxina ptx3 longa para tratamento da infertilidade feminina - Google Patents
Uso de pentraxina ptx3 longa para tratamento da infertilidade femininaInfo
- Publication number
- BR0211619A BR0211619A BR0211619-7A BR0211619A BR0211619A BR 0211619 A BR0211619 A BR 0211619A BR 0211619 A BR0211619 A BR 0211619A BR 0211619 A BR0211619 A BR 0211619A
- Authority
- BR
- Brazil
- Prior art keywords
- ptx3
- treatment
- pentraxine
- female
- female infertility
- Prior art date
Links
- 206010021928 Infertility female Diseases 0.000 title abstract 2
- 208000007984 Female Infertility Diseases 0.000 title 1
- 230000035558 fertility Effects 0.000 abstract 4
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 abstract 3
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 abstract 3
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 101150095640 PTX3 gene Proteins 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
Abstract
"USO DE PENTRAXINA PTX3 LONGA PARA TRATAMENTO DA INFERTILIDADE FEMININA". A presente invenção refere-se à atividade do gene PTX3 ou PTX3 equivalente que é necessária para a fertilidade feminina. A manipulação da atividade PTX3 irá regular a fertilidade feminina. Os efeitos da esterilidade feminina podem ser melhorados, a capacidade reprodutiva pode ser aumentada ou diminuída, conforme desejado, a fertilidade feminina pode ser aumentada, ou combinações destes. A necessidade de terapias que afetam da fertilidade feminina é conseguida desse modo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30947201P | 2001-08-03 | 2001-08-03 | |
PCT/IT2002/000473 WO2003011326A1 (en) | 2001-08-03 | 2002-07-18 | Use of long pentraxin ptx3 for treating female infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211619A true BR0211619A (pt) | 2004-08-24 |
Family
ID=23198379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211619-7A BR0211619A (pt) | 2001-08-03 | 2002-07-18 | Uso de pentraxina ptx3 longa para tratamento da infertilidade feminina |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040198655A1 (pt) |
EP (1) | EP1411971B1 (pt) |
JP (1) | JP4312599B2 (pt) |
KR (1) | KR100890999B1 (pt) |
CN (1) | CN1231257C (pt) |
AT (1) | ATE321566T1 (pt) |
AU (1) | AU2002324328B2 (pt) |
BR (1) | BR0211619A (pt) |
CA (1) | CA2454421C (pt) |
DE (1) | DE60210297T2 (pt) |
DK (1) | DK1411971T3 (pt) |
ES (1) | ES2261714T3 (pt) |
HK (1) | HK1068797A1 (pt) |
HU (1) | HU228978B1 (pt) |
MX (1) | MXPA04000909A (pt) |
PL (1) | PL205928B1 (pt) |
PT (1) | PT1411971E (pt) |
WO (1) | WO2003011326A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
ITRM20020109A1 (it) * | 2002-02-28 | 2003-08-28 | Sigma Tau Ind Farmaceuti | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
ITRM20030595A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile. |
ITRM20040489A1 (it) | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
EP1874793A4 (en) * | 2005-04-15 | 2008-12-24 | Univ Texas | DISTRIBUTION OF SIRNA BY NEUTRAL LIPID COMPOSITIONS |
WO2007073899A1 (en) * | 2005-12-29 | 2007-07-05 | Humanitas Mirasole S.P.A. | Diagnostic test for inflammatory endothelial dysfunctions in pregnancies |
FR2896588B1 (fr) * | 2006-01-20 | 2016-08-19 | Univ D'angers | Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3. |
RS52377B (en) | 2006-05-02 | 2012-12-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Administration of thymosin 1, alone or in combination with PTX3 or ganciclovir, for the treatment of CITOMEGALOVIRUS INFECTION |
US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
US10162800B2 (en) | 2012-10-17 | 2018-12-25 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
US9836577B2 (en) | 2012-12-14 | 2017-12-05 | Celmatix, Inc. | Methods and devices for assessing risk of female infertility |
SG11201606036PA (en) * | 2014-01-27 | 2016-08-30 | Celmatix Inc | Methods for assessing whether a genetic region is associated with infertility |
CA2954895A1 (en) | 2014-07-17 | 2016-01-21 | Celmatix Inc. | Methods and systems for assessing infertility and related pathologies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
-
2002
- 2002-07-18 DK DK02758773T patent/DK1411971T3/da active
- 2002-07-18 CA CA2454421A patent/CA2454421C/en not_active Expired - Fee Related
- 2002-07-18 BR BR0211619-7A patent/BR0211619A/pt not_active IP Right Cessation
- 2002-07-18 US US10/485,640 patent/US20040198655A1/en not_active Abandoned
- 2002-07-18 PL PL368413A patent/PL205928B1/pl not_active IP Right Cessation
- 2002-07-18 HU HU0400662A patent/HU228978B1/hu not_active IP Right Cessation
- 2002-07-18 MX MXPA04000909A patent/MXPA04000909A/es active IP Right Grant
- 2002-07-18 ES ES02758773T patent/ES2261714T3/es not_active Expired - Lifetime
- 2002-07-18 DE DE60210297T patent/DE60210297T2/de not_active Expired - Lifetime
- 2002-07-18 CN CNB028152948A patent/CN1231257C/zh not_active Expired - Fee Related
- 2002-07-18 EP EP02758773A patent/EP1411971B1/en not_active Expired - Lifetime
- 2002-07-18 WO PCT/IT2002/000473 patent/WO2003011326A1/en active IP Right Grant
- 2002-07-18 JP JP2003516556A patent/JP4312599B2/ja not_active Expired - Fee Related
- 2002-07-18 KR KR1020047001689A patent/KR100890999B1/ko not_active IP Right Cessation
- 2002-07-18 AU AU2002324328A patent/AU2002324328B2/en not_active Ceased
- 2002-07-18 AT AT02758773T patent/ATE321566T1/de active
- 2002-07-18 PT PT02758773T patent/PT1411971E/pt unknown
-
2005
- 2005-02-16 HK HK05101268A patent/HK1068797A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2261714T3 (es) | 2006-11-16 |
KR100890999B1 (ko) | 2009-03-31 |
AU2002324328B2 (en) | 2007-09-06 |
CN1231257C (zh) | 2005-12-14 |
ATE321566T1 (de) | 2006-04-15 |
CN1538849A (zh) | 2004-10-20 |
EP1411971A1 (en) | 2004-04-28 |
WO2003011326A1 (en) | 2003-02-13 |
EP1411971B1 (en) | 2006-03-29 |
DK1411971T3 (da) | 2006-08-07 |
HUP0400662A3 (en) | 2010-01-28 |
PL368413A1 (en) | 2005-03-21 |
KR20040019107A (ko) | 2004-03-04 |
PL205928B1 (pl) | 2010-06-30 |
PT1411971E (pt) | 2006-07-31 |
HU228978B1 (en) | 2013-07-29 |
CA2454421C (en) | 2013-03-12 |
HK1068797A1 (en) | 2005-05-06 |
US20040198655A1 (en) | 2004-10-07 |
MXPA04000909A (es) | 2004-03-26 |
CA2454421A1 (en) | 2003-02-13 |
JP2005502640A (ja) | 2005-01-27 |
JP4312599B2 (ja) | 2009-08-12 |
DE60210297D1 (de) | 2006-05-18 |
DE60210297T2 (de) | 2007-01-11 |
HUP0400662A2 (hu) | 2004-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211619A (pt) | Uso de pentraxina ptx3 longa para tratamento da infertilidade feminina | |
BR112019021507A8 (pt) | Montagem microcirúrgica robótica | |
BR0208636A (pt) | Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com infncia | |
BRPI0409678A (pt) | métodos para identificar um composto, para tratar ou prevenir uma doença ou distúrbio em um humano, para incrementar a função de órgãos, tecidos, ou células excitáveis em um humano e para modular a atividade de um complexo de receptores de citocinas protetor de tecidos em um humano | |
BR9902191A (pt) | Artigo absorvente | |
BR9707325A (pt) | Processo para o tratamento de um paciente afetado com uma doença mediada por il-1, composição farmacéutica e uso da mesma | |
BR9809968A (pt) | Aplicação de derivados tiazolidinadiona no tratamento da pcos e diabetes gestacional | |
BR0314943A (pt) | Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes | |
BRPI0704238A (pt) | preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica | |
BR0115847A (pt) | Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos | |
UY28130A1 (es) | Compuestos de indazol y composiciones farmaceuticaspara inhibr proteinquinasas, y procedimientos para su uso. | |
ES2131973T3 (es) | Empleo de 2-amino-4-(4-fluorobencilamino)-1-etoxicarbonilaminobencenos para la profilaxis y el tratamiento de las secuelas de la disminucion aguda y cronica del riego sanguineo cerebral, asi como de afecciones neurodegenerativas. | |
BR0211978A (pt) | Terapia de combinação para o tratamento de câncer | |
ES2144239T3 (es) | Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
ES2192680T3 (es) | Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
BR0210013A (pt) | Gel oftálmico de pirenzepina | |
BR112022011445A2 (pt) | Composição imunoestimuladora e uso da mesma | |
BR9803233A (pt) | Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares. | |
BR0212245A (pt) | Composição emulsificante, agente de engraxamento para engraxar couro, uso da composição emulsificante, e, processo para engraxar couro e peles | |
BR0210269A (pt) | Absorvente labial possuindo vários dispositivos | |
BR0114411A (pt) | métodos e composições para o tratamento de doenças inflamatórias | |
BR0012408A (pt) | Métodos para induzir ou aumentar a migração celular, para reduzir ou inibir a migração celular, para induzir ou aumentar a cura de ferimento em um paciente, e para regular a expressão de pelo menos um gene de uma célula, e, uso de um agonista de fator de tecido | |
BRPI0418138A (pt) | medicamento compreendendo ptx3, sozinho ou em combinação com tsg-6, para tratar doenças degenerativas de cartilagem e ósseas e tratar infertilidade feminina | |
PT1331940E (pt) | Utilizacao da pentraxina longa ptx3 para o tratamento de doencas provocadas por uma activacao alterada do factor de crescimento fgf-2 | |
BRPI0516554A (pt) | pentraxina ptx3 longa desglicosilada e dessialidada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2315 DE 19-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |